Methodological considerations for group-based multi-trajectory modeling of serum electrolytes in pre-ESRD patients [0.03%]
透析前期患者血清电解质多轨迹群体建模的方法学考虑事项
Sutong Liu,Chen Wang
Sutong Liu
Comment on "Detecting asymptomatic cement pulmonary embolisms following vertebral augmentation using dual-energy computed tomography pulmonary angiography" [0.03%]
关于“使用双能量CT肺血管造影检测椎体增强术后无症状水泥肺栓子”的点评
Ajit Kumar Ojah,Dipika Das,Sanjeeb Mallick
Ajit Kumar Ojah
Response to commentary on "Paracentesis exceeding three liters increases risks of acute kidney injury even in cirrhotic patients with albumin infused refractory ascites" [0.03%]
关于“大量腹水难治性腹水患者行超过3升的腹腔穿刺术增加急性肾损伤风险”一文的观点回应
Pei-Shan Wu,Kuei-Chuan Lee,Chih-Yu Li et al.
Pei-Shan Wu et al.
Comment on "Follow-up of inguinal hernia repairs using a modified Kugel mesh without the optional onlay mesh for more than 10 years" [0.03%]
关于“改良式Kugel补片疝修补术(不使用可选的外置补片)10余年随访”的述评
Chun-Kai Chang,Hao-Han Chang
Chun-Kai Chang
Comment on "Consensus of the Taiwanese dermatological association and Taiwan lung cancer society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience." [0.03%]
台湾皮肤科医学会和台湾肺癌学会关于非小细胞肺癌酪氨酸激酶抑制剂相关性皮肤毒性的预防和管理共识(结合台湾治疗经验更新版)的评论
D R Shivaraj
D R Shivaraj
Comment on "Physicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapies" [0.03%]
关于“医务人员、案主和HCV患者推荐了一种简化的基线检测和DAA治疗HCV感染的最少监测策略”的述评
Ravindra Mishra,Kartik,Vinay Jain
Ravindra Mishra
2026 Consensus and review of Lipoprotein(a) from Taiwan Society of Lipid and Atherosclerosis: Molecular pathogenesis, epidemiology, clinical implications, and advances in diagnostic strategies [0.03%]
台湾血脂与动脉硬化学会2026年脂蛋白(a)共识及文献回顾:分子病理学、流行病学、临床意义和诊断策略的最新进展
Chao-Yun Cheng,Yih-Jer Wu,Chih-Fan Yeh et al.
Chao-Yun Cheng et al.
Lipoprotein(a) [Lp(a)] is a genetically determined lipoprotein that has been established as an independent and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Structurally comp...